Last reviewed · How we verify
NCT03522025
GMK-UNI Anatomical UKA: Fixation of Cemented vs Cementless Designs
NA trial testing Unicompartmental Knee Arthroplasty (UKA) in Osteoarthritis, Knee in 70 participants. Participants enrolled and being followed up; not accepting new ones.
1 December 2026
Quick facts
| Lead sponsor | Medacta International SA |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 70 |
| Start date | 15 February 2019 |
| Primary completion | 1 December 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 5 locations across France, Switzerland |
Drugs / interventions tested
- Unicompartmental Knee Arthroplasty (UKA)
Conditions studied
- Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →
Sponsor
Medacta International SA — full company profile →
Who can join
Adults 18 to 95, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Unicompartmental knee arthroplasty (UKA) is the principal surgical alternative to the total knee arthroplasty (TKA) in patients with end-stage unicompartmental tibiofemoral osteoarthritis (OA) of the knee. The current comparative randomized study aims to evaluate the fixation of cemented and cementless designs of GMK-UNI unicompartmental knee prosthesis over a 5-year time period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03522025
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Unicompartmental Knee Arthroplasty (UKA)
Trials testing the same drug.
- NCT05735847 — Surgery Induced Trauma After Total Versus Medial Unicompartmental Knee Arthroplasty (SITA) · active not recruiting
Other recruiting trials for Osteoarthritis, Knee
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
- NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
- NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
- NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting
Other Medacta International SA trials
Trials by the same sponsor.
- NCT06775704 — Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System · recruiting
- NCT06640764 — Multicentre SMS Study - FR · recruiting
- NCT06578897 — A Post-Market, Retrospective Study on 3D Metal Tibial and Femoral Cones · completed
- NCT05679232 — Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty · NA · recruiting
- NCT05785364 — A Post Market Surveillance Study About the MONOCER Cup · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03522025 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medacta International SA
- Last refreshed: 25 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03522025.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing